FR2374914A1 - Composition anti-microbienne, procede en comportant application, notamment un procede d'induction d'anesthesie topique - Google Patents

Composition anti-microbienne, procede en comportant application, notamment un procede d'induction d'anesthesie topique

Info

Publication number
FR2374914A1
FR2374914A1 FR7634948A FR7634948A FR2374914A1 FR 2374914 A1 FR2374914 A1 FR 2374914A1 FR 7634948 A FR7634948 A FR 7634948A FR 7634948 A FR7634948 A FR 7634948A FR 2374914 A1 FR2374914 A1 FR 2374914A1
Authority
FR
France
Prior art keywords
carbon atoms
microbial
primary
tertiary
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7634948A
Other languages
English (en)
Other versions
FR2374914B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johnson and Johnson
Original Assignee
Johnson and Johnson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson and Johnson filed Critical Johnson and Johnson
Publication of FR2374914A1 publication Critical patent/FR2374914A1/fr
Application granted granted Critical
Publication of FR2374914B1 publication Critical patent/FR2374914B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N31/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
    • A01N31/02—Acyclic compounds
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N31/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
    • A01N31/04—Oxygen or sulfur attached to an aliphatic side-chain of a carbocyclic ring system
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N31/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
    • A01N31/08—Oxygen or sulfur directly attached to an aromatic ring system
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N31/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
    • A01N31/08—Oxygen or sulfur directly attached to an aromatic ring system
    • A01N31/14—Ethers
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N31/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
    • A01N31/08—Oxygen or sulfur directly attached to an aromatic ring system
    • A01N31/16—Oxygen or sulfur directly attached to an aromatic ring system with two or more oxygen or sulfur atoms directly attached to the same aromatic ring system
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N33/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic nitrogen compounds
    • A01N33/02—Amines; Quaternary ammonium compounds
    • A01N33/08—Amines; Quaternary ammonium compounds containing oxygen or sulfur
    • A01N33/10—Amines; Quaternary ammonium compounds containing oxygen or sulfur having at least one oxygen or sulfur atom directly attached to an aromatic ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A61K8/416—Quaternary ammonium compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Environmental Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

La présente invention concerne des compositions anti-microbiennes. Cette composition anti-microbienne comprend un agent anti-microbien et un agent potentiateur, l'agent potentiateur est un dérivé d'alcool ou de phénol choisi parmi le groupe consistant de a des alcools monohydriques primaires, secondaires et tertiaires à chaîne aliphatique droite ou ramifiée dans lesquels les alcools à chaîne droite ont environ de 5 à environ 10 atomes de carbone; et les alcools à chaîne ramifiée ont environ jusqu'à 17 atomes de carbone, leur chaîne droite la plus longue de liaisons carbone-carbone ayant environ de 5 à environ 10 atomes de carbone; b un cyclohexylalcanol ou un alcoylcyclohexylalcanol primaire, secondaire ou tertiaire dans lequel l'alcanol est complètement défini ci-après; c un phénylalcanol, un halophénylalcanol ou un alcoylphénylalcanol en C1 -C3 primaire, secondaire ou tertiaire dans lequel l'alcanol possède environ de 3 à environ 9 atomes de carbone; d un cyclohexylphénol qui peut avoir un substituant sur le noyau phényle choisi parmi les groupes consistant d'un groupe alcoyle en C1 -C3 et alcoxy, hydroxyle, halo, amino et des substituants amino-alcoyle et dialcoyle. Cette composition trouve des applications spéciales notamment sous forme de solution de nettoyage chirurgical, sous forme d'anesthésique topique, d'agent de régulation cellulaire, de composition anti-microbienne de composition anti-inflammatoire, etc.
FR7634948A 1974-07-08 1976-11-19 Composition anti-microbienne, procede en comportant application, notamment un procede d'induction d'anesthesie topique Granted FR2374914A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48628774A 1974-07-08 1974-07-08
US05/748,868 US4091090A (en) 1974-07-08 1976-12-10 Potentiated anesthetics

Publications (2)

Publication Number Publication Date
FR2374914A1 true FR2374914A1 (fr) 1978-07-21
FR2374914B1 FR2374914B1 (fr) 1980-04-04

Family

ID=27048631

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7634948A Granted FR2374914A1 (fr) 1974-07-08 1976-11-19 Composition anti-microbienne, procede en comportant application, notamment un procede d'induction d'anesthesie topique

Country Status (6)

Country Link
US (1) US4091090A (fr)
AU (2) AU513753B2 (fr)
BE (1) BE848880A (fr)
FR (1) FR2374914A1 (fr)
GB (2) GB1569424A (fr)
NL (1) NL7613239A (fr)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7713618L (sv) * 1977-12-01 1979-06-02 Astra Laekemedel Ab Lokalanestetisk blandning
DE3139358C2 (de) * 1981-10-02 1984-06-07 Dragoco Gerberding & Co Gmbh, 3450 Holzminden Verwendung von 1,1-Di(C↓1↓-C↓6↓-alkyl)-2-phenyl-ethan-Derivaten als Riechstoffe
CH655656B (fr) * 1982-10-07 1986-05-15
DE3332505A1 (de) * 1983-09-09 1985-03-28 Henkel Kgaa Sebosuppressive kosmetische mittel, enthaltend alkoxyarylalkanole
US4626539A (en) * 1984-08-10 1986-12-02 E. I. Dupont De Nemours And Company Trandermal delivery of opioids
US4895727A (en) * 1985-05-03 1990-01-23 Chemex Pharmaceuticals, Inc. Pharmaceutical vehicles for exhancing penetration and retention in the skin
GB8604986D0 (en) * 1986-02-28 1986-04-09 Unilever Plc Disinfectant compositions
GB8625103D0 (en) * 1986-10-20 1986-11-26 Unilever Plc Disinfectant compositions
US4913894A (en) * 1987-09-11 1990-04-03 Colgate-Palmolive Company Appetite suppressant dentifrice
US4935225A (en) * 1987-09-11 1990-06-19 Curtis John P Appetite suppresant dentifrice
US4885154A (en) * 1988-03-01 1989-12-05 Alza Corporation Method for reducing sensitization or irritation in transdermal drug delivery and means therefor
US4902692A (en) * 1988-03-18 1990-02-20 Iolab Corporation Method and composition for ophthalmic anesthesia using rodocaine
US5006510A (en) * 1989-06-20 1991-04-09 Ellis Wladislaw V Method for relieving chronic pain with a somatostatin analog composition
US5480869A (en) * 1990-01-09 1996-01-02 The Regents Of The University Of California Anti-inflammatory peptide analogs and treatment to inhibit vascular leakage in injured tissues
US5192527A (en) * 1991-07-01 1993-03-09 Abrahmsohn Glenn M Method of reversing local anesthesia and reagent system therefor
US5374621A (en) * 1991-09-13 1994-12-20 Regents Of The University Of California Neurotensin method for inhibiting vascular leakage
DE4225795C2 (de) * 1992-07-31 1994-09-01 Schuelke & Mayr Gmbh Desinfektionsmittel auf Carbonsäurebasis
DE4234225A1 (de) * 1992-10-10 1994-04-14 Roehm Pharma Gmbh Stabile topische Formulierungen mit gutem Wirkstoff-Freisetzungsvermögen enthaltend mindestens ein lipophilisiertes Makrolidantibiotikum
AU4031593A (en) * 1993-03-11 1994-09-26 Procter & Gamble Company, The Throat compositions
US5414014A (en) * 1993-04-08 1995-05-09 Innova Biomed, Inc. Methods for efficacious removal of attached, sucking antropods from human dermis
US5547677A (en) * 1994-05-20 1996-08-20 Novavax, Inc. Antimicrobial oil-in-water emulsions
EP0760650B1 (fr) * 1994-05-20 2002-07-31 Novavax, Inc. Emulsions huile-dans-eau antimicrobiennes
DE19521364A1 (de) * 1995-06-12 1996-12-19 Henkel Kgaa Cyclohexyl-substituierte Alkanole
US5776859A (en) * 1995-11-15 1998-07-07 Nickel; Alfred A. Sodium channel active novel compounds and related processes and bioassay techniques
US6576633B1 (en) 1996-02-22 2003-06-10 The Dow Chemical Company Stable liquid antimicrobial suspension compositions containing quarternaries prepared from hexamethylenetetramine and certain halohydrocarbons
US6228840B1 (en) * 1998-02-27 2001-05-08 Edward T. Wei Melanocortin receptor antagonists and modulations of melanocortin receptor activity
US6187727B1 (en) 1999-07-12 2001-02-13 Bush Boake Allen, Inc. Fragrance materials
US6172016B1 (en) 1999-07-12 2001-01-09 Bush Boakes Allen Inc. Fragrance materials
GB0015617D0 (en) * 2000-06-26 2000-08-16 Vectura Ltd Improved preparations for dermal delivery of active substances
USRE44145E1 (en) 2000-07-07 2013-04-09 A.V. Topchiev Institute Of Petrochemical Synthesis Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
EP1390084B1 (fr) * 2001-05-01 2011-03-23 A.V. Topchiev Institute of Petrochemical Synthesis Composition bioadhesive biphase absorbant l'eau
US20050113510A1 (en) 2001-05-01 2005-05-26 Feldstein Mikhail M. Method of preparing polymeric adhesive compositions utilizing the mechanism of interaction between the polymer components
US8206738B2 (en) 2001-05-01 2012-06-26 Corium International, Inc. Hydrogel compositions with an erodible backing member
US8541021B2 (en) * 2001-05-01 2013-09-24 A.V. Topchiev Institute Of Petrochemical Synthesis Hydrogel compositions demonstrating phase separation on contact with aqueous media
US20050215727A1 (en) 2001-05-01 2005-09-29 Corium Water-absorbent adhesive compositions and associated methods of manufacture and use
US8840918B2 (en) 2001-05-01 2014-09-23 A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences Hydrogel compositions for tooth whitening
JP4116447B2 (ja) 2001-05-01 2008-07-09 エイ．ブイ．トップチーブ インスティテュート オブ ペトロケミカル シンセシス ヒドロゲル組成物
CA2446060A1 (fr) * 2001-05-07 2002-11-14 Corium International Compositions et systemes d'administration d'un anesthesique local
US6894078B2 (en) * 2001-09-17 2005-05-17 James G. Castillo Alcohol based topical anesthetic formulation and method
CN1929819B (zh) 2004-01-30 2012-02-29 考里安国际公司 递送活性剂的快速溶解膜
EP1791575B1 (fr) * 2004-08-05 2014-10-08 Corium International, Inc. Composition d'adhesif
DE102005002010A1 (de) * 2005-01-15 2006-07-20 Symrise Gmbh & Co. Kg Verwendung von 2,2-Dimethyl-3-cyclohexyl-1-propanol als Riechstoff
US9283177B2 (en) * 2007-01-16 2016-03-15 Juventio, Llc Topical anesthetic for rapid local anesthesia and method of applying a topical anesthetic
WO2008089242A1 (fr) * 2007-01-16 2008-07-24 Dermworx, Incorporated Anesthésique topique pour anesthésie locale rapide et méthode d'application d'un anesthésique topique
DE102008043586A1 (de) * 2007-11-12 2009-05-14 Symrise Gmbh & Co. Kg Riechstoffakkorde zur Bekämpfung der Wahrnehmung von Körpergeruch
EP2133102B1 (fr) 2008-03-19 2014-12-03 Symrise AG Substances réduisant l'odeur
EP2307357A1 (fr) * 2008-05-30 2011-04-13 Symrise AG L-menthyl-n-(2-hydroxyphényl)carbamate
WO2010008600A1 (fr) * 2008-07-16 2010-01-21 Dermworx Incorporated Système d'apport de médicament topique
CA2751884C (fr) 2009-01-14 2018-09-25 Corium International, Inc. Administration transdermique de tamsulosine
EP2424829B1 (fr) 2009-04-28 2015-01-07 Symrise AG Oméga-cyclohexylalcan-1-oles et leur utilisation comme antimicrobiens actifs pour lutter contre les odeurs corporelles
CN104271109A (zh) * 2012-04-25 2015-01-07 默克专利股份有限公司 具有抗微生物性质的二环己基甲醇衍生物的用途
EP2662434B2 (fr) 2012-05-10 2023-08-16 Symrise AG Utilisation de certaines liaisons pour augmenter des odeurs
US20140170593A1 (en) * 2012-12-18 2014-06-19 Oltuse, Llc Patch for non-invasive pain relief
EP2966158B2 (fr) 2014-07-07 2024-03-13 Symrise AG Mélanges d'isomères de composés musqués macrocyliques insaturés
EP2966159B1 (fr) 2014-07-07 2017-02-22 Symrise AG Mélanges d'isomères E enrichis de composés musqués macrocycliques insaturées
US20170245496A1 (en) * 2014-08-12 2017-08-31 Georgia State University Research Foundation, Inc. Volatile organic compounds for inhibiting fungal growth
US11517525B2 (en) * 2015-09-18 2022-12-06 Hikma Pharmaceuticals Usa Inc. Epinephrine spray formulations
US11571384B2 (en) * 2015-09-18 2023-02-07 Hikma Pharmaceuticals Usa Inc. Epinephrine spray formulations
PL3654973T3 (pl) 2017-07-18 2022-01-17 Katholieke Universiteit Leuven Kompozycje przeciwko zakażeniom Candida
EP3880163A1 (fr) 2018-11-12 2021-09-22 Symrise AG Utilisation de dérivés de 1-éthyl-4,4-diméthyl-cyclohexane comme substances odoriférantes
CN112969774A (zh) 2018-11-13 2021-06-15 西姆莱斯有限公司 具有铃兰香味的加香成分
US20220049183A1 (en) 2018-12-20 2022-02-17 Symrise Ag Alicyclic musk fragrance compounds
WO2023213381A1 (fr) 2022-05-03 2023-11-09 Symrise Ag Nouveaux composés de parfum

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5958M (fr) * 1966-11-09 1968-04-16

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3891757A (en) * 1971-11-11 1975-06-24 Alza Corp Anaesthetic topical and percutaneous administration with selected promoters

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5958M (fr) * 1966-11-09 1968-04-16

Also Published As

Publication number Publication date
GB1569424A (en) 1980-06-18
FR2374914B1 (fr) 1980-04-04
US4091090A (en) 1978-05-23
AU5909780A (en) 1980-09-11
BE848880A (fr) 1977-05-31
NL7613239A (nl) 1978-05-30
AU513753B2 (en) 1980-12-18
AU1969576A (en) 1978-05-25
AU534455B2 (en) 1984-02-02
GB1569423A (en) 1980-06-18

Similar Documents

Publication Publication Date Title
FR2374914A1 (fr) Composition anti-microbienne, procede en comportant application, notamment un procede d'induction d'anesthesie topique
CA1226220A (fr) Produit et methode de traitement de l'acne
NO308470B1 (no) Hypolipidemiske benzotiazepiner, anvendelse derav, kjemisk forbindelse og farmasøytisk blanding
IE801626L (en) 4-benzyl- and 4-benzoyl-imidazoles
KR830006174A (ko) 기관지 항경련성 화합물 제조방법
CA2468747A1 (fr) Utilisation de pramipexole pour traiter la sclerose laterale amyotrophique
TNSN92008A1 (fr) Steroides-esters nouveaux
BR9306163A (pt) Agente de limpeza para superfícies duras
PE20001378A1 (es) Azalidas de 13 miembros
DE2519394C3 (de) Mittel zur Behandlung von Herpessimplex Virusinfektionen
US4182752A (en) Neocarzinostatin derivatives and a process for producing the same
Calderon et al. A comparison between quinacrine fluorescence banding and 3H-thymidine incorporation patterns in human chromosomes
ATE284217T1 (de) Verwendung von sulphoquinovosyldiacylglycerols zur behandlung von entzündlichen hauterkrankungen
HUP9802757A2 (hu) Új naftalénszármazékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyászati készítmények
FR2403800A1 (fr) Composition de traitement de la peau a activite antivirale
WO2011096688A2 (fr) Composition pour améliorer la santé du cuir chevelu et des cheveux comprenant un dérivé de dibenzo-p-dioxine
EP0386826B2 (fr) Mélanges d'acides gras amidés et leur utilisation comme épaississants
US3027301A (en) Therapeutic wound healing composition of hydroxypropylamides of hydroxybenzoic acids
Selye et al. An experimental model of “dermatomyositis” induced by calciphylaxis
US5446027A (en) Amide derivative and external skin care preparation containing the same
BR9508518A (pt) 8-Flúor-antraciclinas processo para sua preparação e compsição farmacéutica contendo as mesma
Porter et al. 4, 4, 6-Trimethyl-3, 4-dihydropyrimidine-2-thiol, an effective inhibitor of dopamine-β-hydroxylation in vivo
TR199900725T2 (xx) Hidroksamik asit t�revleri
FR2358884A1 (fr) Compositions d'amino-alcools et leur procede de preparation et leur application notamment pour le traitement d'affections buccales
US3842120A (en) 2-methyl-2-(p-(n-phenylformimidoyl)phenoxy)propionic acid esters and congeners